Advances with Lipid-Based Nanosystems for siRNA Delivery to Breast Cancers

Breast cancer is the most frequently diagnosed cancer among women. Breast cancer is also the key reason for worldwide cancer-related deaths among women. The application of small interfering RNA (siRNA)-based drugs to combat breast cancer requires effective gene silencing in tumor cells. To overcome...

Descripción completa

Detalles Bibliográficos
Autores principales: Subhan, Md Abdus, Filipczak, Nina, Torchilin, Vladimir P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10386415/
https://www.ncbi.nlm.nih.gov/pubmed/37513882
http://dx.doi.org/10.3390/ph16070970

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10386415/
https://www.ncbi.nlm.nih.gov/pubmed/37513882
http://dx.doi.org/10.3390/ph16070970

Ejemplares similares